Medullary thyroid carcinoma: biology, management, and treatment of sporadic and hereditary MTC
What is new? -- Thyroid C-Cell Biology and Oncogenic Transformation -- Histopathology of C cells and medullary thyroid carcinoma -- Epidemiology and clinical presentation of Medullary Thyroid Carcinoma -- Medullary thyroid carcinoma: Imaging -- Calcitonin as a Biomarker for Medullary Thyroid Carcino...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Buch/Monographie |
| Sprache: | Englisch |
| Veröffentlicht: |
Cham
Springer Nature Switzerland
2025.
Cham Imprint: Springer 2025. |
| Ausgabe: | 2nd ed. 2025. |
| Schriftenreihe: | Recent Results in Cancer Research
223 |
| DOI: | 10.1007/978-3-031-80396-3 |
| Online-Zugang: | Resolving-System, lizenzpflichtig: https://doi.org/10.1007/978-3-031-80396-3
|
| Verfasserangaben: | edited by Friedhelm Raue, Karin Frank-Raue |
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 192050303X | ||
| 003 | DE-627 | ||
| 005 | 20250415084426.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250325s2025 sz |||||o 00| ||eng c | ||
| 020 | |a 9783031803963 |9 978-3-031-80396-3 | ||
| 024 | 7 | |a 10.1007/978-3-031-80396-3 |2 doi | |
| 035 | |a (DE-627)192050303X | ||
| 035 | |a (DE-599)KEP113240821 | ||
| 035 | |a (DE-He213)978-3-031-80396-3 | ||
| 035 | |a (DE-627-1)113240821 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-CH | ||
| 072 | 7 | |a MJCL |2 bicssc | |
| 072 | 7 | |a MED062000 |2 bisacsh | |
| 082 | 0 | |a 616.994 |2 23 | |
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Medullary thyroid carcinoma |b biology, management, and treatment of sporadic and hereditary MTC |c edited by Friedhelm Raue, Karin Frank-Raue |
| 250 | |a 2nd ed. 2025. | ||
| 264 | 1 | |a Cham |b Springer Nature Switzerland |c 2025. | |
| 264 | 1 | |a Cham |b Imprint: Springer |c 2025. | |
| 300 | |a 1 Online-Ressource (XVI, 307 p. 48 illus., 30 illus. in color.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Recent Results in Cancer Research |v 223 | |
| 520 | |a What is new? -- Thyroid C-Cell Biology and Oncogenic Transformation -- Histopathology of C cells and medullary thyroid carcinoma -- Epidemiology and clinical presentation of Medullary Thyroid Carcinoma -- Medullary thyroid carcinoma: Imaging -- Calcitonin as a Biomarker for Medullary Thyroid Carcinoma -- Hereditary Medullary Thyroid Cancer, Genotype phenotype correlation -- Pheochromocytomas in Multiple Endocrine Neoplasia type 2 -- Primary hyperparathyroidism in Multiple Endocrine Neoplasia 2 Syndrome -- Surgical treatment of medullary thyroid carcinoma -- Long term follow up in medullary thyroid carcinoma -- Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma. | ||
| 520 | |a After 10 years, this second edition is extensively rewritten and updated and provides a source of information concerning all aspects of medullary thyroid carcinoma, including comprehensive actual references for interested scientists. Medullary thyroid carcinoma (MTC) is a rare unique tumor which differs from other thyroid tumors by originating from the neuroendocrine C-cell, secreting the specific tumor marker calcitonin. MTC is associated in about 25% of cases with multiple endocrine neoplasia type 2, an autosomal dominant familial disorder causing tumors within various endocrine glands. The molecular genetics of tumor development is clarified: hereditary as well as sporadic MTC are linked to mutations in the RET proto- oncogene coding for a tyrosine kinase. These RET mutations serve as a genetic marker for hereditary MTC and allow for prophylactic thyroidectomy in gene carriers. The RET-tyrosine kinase is also a new therapeutic target using selective tyrosine kinase inhibitors improving the outcome of advanced metastasized MTC. This book will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians. | ||
| 650 | 0 | |a Oncology. | |
| 650 | 0 | |a Endocrinology. | |
| 650 | 0 | |a Pediatrics. | |
| 650 | 0 | |a Medical genetics. | |
| 650 | 0 | |a Nuclear medicine. | |
| 700 | 1 | |a Raue, Friedhelm |e HerausgeberIn |0 (DE-588)1084837749 |0 (DE-627)848756681 |0 (DE-576)169747719 |4 edt | |
| 700 | 1 | |a Frank-Raue, Karin |e HerausgeberIn |0 (DE-588)1094920584 |0 (DE-627)85537957X |0 (DE-576)168566591 |4 edt | |
| 776 | 1 | |z 9783031803956 | |
| 776 | 1 | |z 9783031803970 | |
| 776 | 1 | |z 9783031803987 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031803956 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031803970 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031803987 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-80396-3 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
| 912 | |a ZDB-2-SEB |b 2025 | ||
| 912 | |a ZDB-2-SME |b 2025 | ||
| 912 | |a ZDB-2-SXM |b 2025 | ||
| 951 | |a BO | ||
| 992 | |a 20250415 | ||
| 993 | |a Book | ||
| 994 | |a 2025 | ||
| 998 | |g 1094920584 |a Frank-Raue, Karin |m 1094920584:Frank-Raue, Karin |d 50000 |e 50000PF1094920584 |k 0/50000/ |p 2 |y j | ||
| 998 | |g 1084837749 |a Raue, Friedhelm |m 1084837749:Raue, Friedhelm |d 50000 |e 50000PR1084837749 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN192050303X |e 4705528220 | ||
| BIB | |a Y | ||
| JSO | |a {"physDesc":[{"extent":"1 Online-Ressource (XVI, 307 p. 48 illus., 30 illus. in color.)"}],"type":{"media":"Online-Ressource","bibl":"edited-book"},"language":["eng"],"recId":"192050303X","name":{"displayForm":["edited by Friedhelm Raue, Karin Frank-Raue"]},"person":[{"family":"Raue","given":"Friedhelm","roleDisplay":"HerausgeberIn","display":"Raue, Friedhelm","role":"edt"},{"role":"edt","display":"Frank-Raue, Karin","roleDisplay":"HerausgeberIn","given":"Karin","family":"Frank-Raue"}],"origin":[{"publisherPlace":"Cham ; Cham","edition":"2nd ed. 2025.","editionNo":2,"dateIssuedKey":"2025","dateIssuedDisp":"2025.","publisher":"Springer Nature Switzerland ; Imprint: Springer"}],"title":[{"title_sort":"Medullary thyroid carcinoma","subtitle":"biology, management, and treatment of sporadic and hereditary MTC","title":"Medullary thyroid carcinoma"}],"id":{"isbn":["9783031803963"],"doi":["10.1007/978-3-031-80396-3"],"eki":["192050303X"]}} | ||
| SRT | |a MEDULLARYT2025 | ||